CN1519374A - Polymorphism of 19th exon in TRPC7 gene - Google Patents
Polymorphism of 19th exon in TRPC7 gene Download PDFInfo
- Publication number
- CN1519374A CN1519374A CNA031150691A CN03115069A CN1519374A CN 1519374 A CN1519374 A CN 1519374A CN A031150691 A CNA031150691 A CN A031150691A CN 03115069 A CN03115069 A CN 03115069A CN 1519374 A CN1519374 A CN 1519374A
- Authority
- CN
- China
- Prior art keywords
- exon
- seq
- gene
- single nucleotide
- trpc7 gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
A single nucleotide polymorphism (SNP) for the extron No.19 of TRPC7 gene and a method for analyzing the SNP and activity of said extron No.19 are disclosed. Said SNP is A->G polymorphism at the site No.232 in its sequence shown by SEQ ID No.1 and can cause the change Ile(I)->Val(V) at the site No.4 of coding protein, so changing protein activity.
Description
Technical field
The present invention relates to the single nucleotide polymorphism of the ten No. nine exon of TRPC7 gene.The invention still further relates to the method for the allelic mutation of analyzing the ten No. nine exon of TRPC7 gene.
Background technology
TRPC7 (transient receptor potential-related channels) is the calciphorin of high expression level in a kind of human brain.This albumen has 7 to wear the film functional zone.This proteic TRPC7 gene of encoding has 32 exons.The investigator thinks, this gene very likely is the candidate gene of some genetic diseasess such as hereditary hearing impairment, Knobloch syndromes or the like.(Genomics?1998?Nov?15;54(1):124-31)
Before the application, also there is not the relevant report of the ten No. nine exon polymorphism of TRPC7 gene.
Summary of the invention
Purpose of the present invention just provides the polymorphism and the detection method thereof of the ten No. nine exon of TRPC7 gene.
In a first aspect of the present invention, the method for the single nucleotide polymorphism of the ten No. nine exon of a kind of people of detection TRPC7 gene is provided, it comprises step:
(a) determine the 232nd Nucleotide in sequence shown in the SEQ ID NO:1 of the ten No. nine exon of people TRPC7 gene;
(b) detect whether there is single nucleotide polymorphism in described position.
In a preference, described single nucleotide polymorphism is to have G at the 232nd.
In a second aspect of the present invention, a kind of isolating nucleic acid is provided, it has the sequence shown in the SEQ ID NO:1, and the 232nd is G.
In a third aspect of the present invention, a kind of allele specific nucleic acid primer is provided, its length is 15-50bp, and hybridizes specifically and amplify shown in the SEQ ID NO:1 that contains the ten No. nine exon of people TRPC7 gene the amplified production of the 232nd single nucleotide polymorphism in the sequence.
In a fourth aspect of the present invention, a kind of allele specific oligonucleotide probe is provided, its length is 15-50bp, and hybridizes specifically and detect shown in the SEQ ID NO:1 that contains the ten No. nine exon of people TRPC7 gene the 232nd single nucleotide polymorphism in the sequence.
A kind of test kit comprises:
(1) primer of the ten No. nine exon of specific amplification people TRPC7 gene is right,
(2) detect the ten No. nine exon of amplified production and normal TRPC7 gene and compare the reagent that whether exists variation required, the 232nd single nucleotide polymorphism in the sequence shown in the described SEQ ID NO:1.
Another kind of diagnostic kit comprises: the oligonucleotide probe that the primer that the present invention is above-mentioned and/or the present invention are above-mentioned.
Embodiment
The inventor is by extensive and deep research, had been found that in the coded protein sequence of the ten No. nine exon of TRPC7 gene the 4th Ile (I)-Val (V) polymorphic (be last 232 A-of mRNA〉G polymorphism), finished the present invention on this basis.
According to normal people TRPC7 gene sequencing result, found this SNP.Find that by analysis this SNP causes the 4th amino acids by Ile (I)-Val (V).Because this is the amino acid whose displacement of different properties, therefore, can cause the ten No. nine coded protein-active of exon of TRPC7 gene to change.
The cDNA sequence of the ten No. nine exon of TRPC7 gene is listed in SEQ ID NO:1, and wherein open reading frame is the 223-375 position, and its coded aminoacid sequence is listed in SEQ ID NO:2.The genome sequence of the ten No. nine exon of TRPC7 gene can obtain from GenBank.
Those skilled in the art will appreciate that a large amount of analytical technologies can be used for detecting whether the site exists single nucleotide polymorphism described in the ten No. nine exon of TRPC7 gene.These technology comprise (but being not limited to): dna sequencing, sequencing by hybridization; Enzymatic mispairing cutting, heteroduple analysis, dot blot, oligonucleotide arrays (DNA chip), Mini-sequencing, Taqman technology, molecular beacon etc., sex change high performance liquid chromatography (DHPLC).
On the other hand, detection method of the present invention is used to assess the individual susceptibility of suffering from the ten No. nine exon relative disease of TRPC7 gene.
Being used for specimen of the present invention and being not particularly limited, for detecting SNP, can be DNA or the mRNA that extracting goes out from samples such as blood, tissue.For detect the ten No. nine exon of TRPC7 gene active for, can anyly contain the sample of the ten No. nine exon of TRPC7 gene, as blood etc.
The primer and the probe that are used for the inventive method or detection kit design according to the cDNA sequence (sequence of SEQ ID NO:1) or the genome sequence of the ten No. nine exon of TRPC7 gene, and the synthetic technology of available routine is synthesized and got final product.
Below in conjunction with specific embodiment, further set forth the present invention.Should be understood that these embodiment only to be used to the present invention is described and be not used in and limit the scope of the invention.The experimental technique of unreceipted actual conditions in the following example, usually according to normal condition, people such as Sambrook for example, molecular cloning: laboratory manual (New York:ColdSpring Harbor Laboratory Press, 1989) condition described in, or the condition of advising according to manufacturer.
Embodiment 1
The extracting of gene and order-checking
Extract DNA with conventional phenol chloroform method from people's blood, concentration correction is used for conventional pcr amplification to 20ng/ul.Primer is:
Adopted primer is arranged: 5 '-acggttatgt ctgacccctc t-3 ' (SEQ ID NO:3)
Antisense primer: 5 '-ccagcctctc tcctgcttc-3 ' (SEQ ID NO:4)
The product of the 454bp that amplifies carries out dna sequencing behind the purifying.
Embodiment 2
The acquisition of SNP
The TRPC7 gene is directly checked order.Each sample sequence of measuring is compared, thereby draw the difference of sequence, obtain SNP.
Embodiment 3
Detection kit
Preparation one detects the detection kit of TRPC7 gene-correlation disease susceptibility, and wherein, it is right to contain the following primer that amplifies 232 SNP:
Adopted primer is arranged: 5 '-acggttatgt ctgacccctc t-3 ' (SEQ ID NO:3)
Antisense primer: 5 '-ccagcctctc tcctgcttc-3 ' (SEQ ID NO:4)
Amplified production and normal control are carried out stratographic analysis with sex change high performance liquid chromatograph (DHPLC), can detect 232 A-easily G type SNP.
All quote in this application as a reference at all documents that the present invention mentions, just quoted as a reference separately as each piece document.Should be understood that in addition those skilled in the art can make various changes or modifications the present invention after having read above-mentioned teachings of the present invention, these equivalent form of values fall within the application's appended claims institute restricted portion equally.
SEQCENCE?LISTING
<110〉Research Center of Shanghai Human Genome
<120〉the ten No. nine exon polymorphism of TRPC7 gene
<130>030115
<160>4
<170>PatentIn?version?3.1
<210>1
<211>454
<212>DNA
<213>Homo?sapiens
<220>
<221>CDS
<222>(223)..(375)
<223>
<400>1
acggttatgt?ctgacccctc?ttgctctttg?tggtgctagc?acaaagatgt?cggcagtcca 60
cgagggtgtg?ggggcagccc?caggactgct?cctgggagcc?tcctgcatgc?cgtgtctgtg 120
ctgtgagtgg?cagtgctgtc?tccaccgctg?ctgggcctgc?ctctgggccc?agtgagcatc 180
gggggccagg?agagtgtagc?ccacacaatc?tctgtcctgc?ag?atg?aag?gac?atc 234
Met?Lys?Asp?Ile
1
ttc?ttc?ttc?ctc?ttc?ctg?ctg?gct?gtg?tgg?gtg?gtg?tcc?ttc?ggg?gtg 282
Phe?Phe?Phe?Leu?Phe?Leu?Leu?Ala?Val?Trp?Val?Val?Ser?Phe?Gly?Val
5 10 15 20
gcc?aag?cag?gcc?atc?ctc?atc?cac?aac?gag?cgc?cgg?gtg?gac?tgg?ctg 330
Ala?Lys?Gln?Ala?Ile?Leu?Ile?His?Asn?Glu?Arg?Arg?Val?Asp?Trp?Leu
25 30 35
ttc?cga?ggg?gcc?gtc?tac?cac?tcc?tac?ctc?acc?atc?ttc?ggg?cag 375
Phe?Arg?Gly?Ala?Val?Tyr?His?Ser?Tyr?Leu?Thr?Ile?Phe?Gly?Gln
40 45 50
atcccgggct?acatcgacgg?taggagccgg?gcgccatggg?agctcgggtg?gtgctgccgg 435
gaagcaggag?agaggctgg 454
<210>2
<211>51
<212>PRT
<213>Homo?sapiens
<400>2
Met?Lys?Asp?Ile?Phe?Phe?Phe?Leu?Phe?Leu?Leu?Ala?Val?Trp?Val?Val
1 5 10 15
Ser?Phe?Gly?Val?Ala?Lys?Gln?Ala?Ile?Leu?Ile?His?Asn?Glu?Arg?Arg
20 25 30
Val?Asp?Trp?Leu?Phe?Arg?Gly?Ala?Val?Tyr?His?Ser?Tyr?Leu?Thr?Ile
35 40 45
Phe?Gly?Gln
50
<210>3
<211>21
<212>DNA
<213〉artificial sequence
<220>
<221>misc_feature
<223〉primer
<400>3
acggttatgt?ctgacccctc?t 21
<210>4
<211>19
<212>DNA
<213〉artificial sequence
<220>
<221>misc_feature
<223〉primer
<400>4
ccagcctctc?tcctgcttc 19
Claims (7)
1. method that detects the single nucleotide polymorphism of the ten No. nine exon of people TRPC7 gene is characterized in that it comprises step:
(a) determine the 232nd Nucleotide in sequence shown in the SEQ ID NO:1 of the ten No. nine exon of people TRPC7 gene;
(b) detect whether there is single nucleotide polymorphism in described position.
2. the method for claim 1 is characterized in that, described single nucleotide polymorphism is to have G at the 232nd.
3. an isolating nucleic acid is characterized in that, it has the sequence shown in the SEQ ID NO:1, and the 232nd is G.
4. allele specific nucleic acid primer, it is characterized in that, its length is 15-50bp, and hybridizes specifically and amplify shown in the SEQ ID NO:1 that contains the ten No. nine exon of people TRPC7 gene the amplified production of the 232nd single nucleotide polymorphism in the sequence.
5. an allele specific oligonucleotide probe is characterized in that, its length is 15-50bp, and hybridizes specifically and detect shown in the SEQ ID NO:1 that contains the ten No. nine exon of people TRPC7 gene the 232nd single nucleotide polymorphism in the sequence.
6. diagnostic kit is characterized in that it comprises:
(1) primer of the ten No. nine exon of specific amplification people TRPC7 gene is right,
(2) detect the ten No. nine exon of amplified production and normal TRPC7 gene and compare the reagent that whether exists variation required, the 232nd single nucleotide polymorphism in the sequence shown in the described SEQ ID NO:1.
7. a diagnostic kit is characterized in that it comprises: described primer of claim 4 and/or the described oligonucleotide probe of claim 5.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA031150691A CN1519374A (en) | 2003-01-22 | 2003-01-22 | Polymorphism of 19th exon in TRPC7 gene |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA031150691A CN1519374A (en) | 2003-01-22 | 2003-01-22 | Polymorphism of 19th exon in TRPC7 gene |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1519374A true CN1519374A (en) | 2004-08-11 |
Family
ID=34284113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA031150691A Pending CN1519374A (en) | 2003-01-22 | 2003-01-22 | Polymorphism of 19th exon in TRPC7 gene |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1519374A (en) |
-
2003
- 2003-01-22 CN CNA031150691A patent/CN1519374A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1519374A (en) | Polymorphism of 19th exon in TRPC7 gene | |
CN1519370A (en) | Polymorphism of first exon in TRPC7 gene | |
CN1519372A (en) | Polymorphism of 18th exon in TRPC7 gene | |
CN1519371A (en) | Polymorphism of 18th exon in TRPC7 gene | |
CN1519373A (en) | Polymorphism of 18th exon in TRPC7 gene | |
CN1519378A (en) | Polymorphism of 10th exon in SYNJ1gene | |
CN1519379A (en) | POlymorphism of 15th exon in SYNJ1 gene | |
CN1519356A (en) | Polymorphism of 12th exon in MX1 gene | |
CN1519362A (en) | Polymorphism of 19th exon in PCNT gene | |
CN1519330A (en) | Polymorphism of first exon in ADAMTSI gene | |
CN1519350A (en) | Polymorphism of first exon in ADAMTS1 gene | |
CN1519341A (en) | Polymorphism of 36th exon in PCNT gene | |
CN1519363A (en) | Polymorphism of 27th exon in PCNT gene | |
CN1519340A (en) | Polymorphism of 38th exon in PCNT gene | |
CN1519336A (en) | Polymorphism of fifth exon in PCNT gene | |
CN1519357A (en) | Polymorphism of 10th exon in PCNT gene | |
CN1519358A (en) | Polymorphism of 12th exon in PCNT gene | |
CN1519344A (en) | Polymorphism of 11th exon in DYRK1A gene | |
CN1519380A (en) | Polymorphism of 25th exon in SYNJ1 gene | |
CN1519352A (en) | Polymorphism of 20th exon in LSS gene | |
CN1519368A (en) | Polymorphism of 33th exon in PCNT gene | |
CN1519337A (en) | Polymorphison of 46th exon in PCNT gene | |
CN1519351A (en) | Polymorphism of 7th exon in ITGB2 gene | |
CN1519353A (en) | Polymorphism of third exon in LSS gene | |
CN1519354A (en) | Polymorphism of 7th exon in LSS gene |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |